Historical Stock Price
ACHN historical stock prices picture
Achillion Pharmaceuticals (ACHN) has the following price history information. Looking back at ACHN historical stock prices for the last five trading days, on October 17, 2019, ACHN opened at $6.20, traded as high as $6.27 and as low as $6.13, and closed at $6.20. Trading volume was a total of 22.31M shares. On October 18, 2019, ACHN opened at $6.15, traded as high as $6.21 and as low as $6.07, and closed at $6.09. Trading volume was a total of 6.39M shares. On October 21, 2019, ACHN opened at $6.10, traded as high as $6.15 and as low as $6.09, and closed at $6.13. Trading volume was a total of 3.56M shares. On October 22, 2019, ACHN opened at $6.15, traded as high as $6.19 and as low as $6.13, and closed at $6.16. Trading volume was a total of 4.41M shares. On October 23, 2019, ACHN opened at $6.13, traded as high as $6.16 and as low as $6.05, and closed at $6.08. Trading volume was a total of 8.16M shares.

ACHN Historical Stock Prices By Date:

ACHN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Achillion Pharmaceuticals shares, starting with a $10,000 purchase of ACHN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/23/2009
End date: 10/23/2019
Start price/share: $1.85
End price/share: $6.08
Dividends collected/share: $0.00
Total return: 228.65%
Average Annual Total Return: 12.63%
Starting investment: $10,000.00
Ending investment: $32,871.83
Years: 10.01
Date Open High Low Close Volume
10/17/2019 $6.20 $6.27 $6.13 $6.20 22.31M
10/18/2019 $6.15 $6.21 $6.07 $6.09 6.39M
10/21/2019 $6.10 $6.15 $6.09 $6.13 3.56M
10/22/2019 $6.15 $6.19 $6.13 $6.16 4.41M
10/23/2019 $6.13 $6.16 $6.05 $6.08 8.16M
Achillion Pharmaceuticals is a biopharmaceutical company. Co. is engaged in the discovery and development of small molecule drug therapies for immune system disorders. Co. is advancing orally administered small molecules from its platform that target complement factor D, an essential protein of the alternative pathway. The alternative pathway plays a role in a number of disease conditions, including therapeutic areas of nephrology, hematology, ophthalmology and neurology. Initially Co. is targeting C3 glomerulopathy, and immune complex membranoproliferative glomerulonephritis, two related rare diseases affecting the kidney, and paroxysmal nocturnal hemoglobinuria, a blood disorder.
Date Close
10/17/2019$6.20
10/18/2019$6.09
10/21/2019$6.13
10/22/2019$6.16
10/23/2019$6.08
ACHN is categorized under the Healthcare sector; below are some other companies in the same sector:

ACHV Historical Stock Prices
ACOR Historical Stock Prices
ACRS Historical Stock Prices
ACRX Historical Stock Prices
ACST Historical Stock Prices
ACT Historical Stock Prices
ACUR Historical Stock Prices
ADHD Historical Stock Prices
ADK Historical Stock Prices
ADMA Historical Stock Prices

Also explore: ACHN shares outstanding history


ACHN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.